SCHEMBL7019990

SCHEMBL7019990

Brc1ccnc(N2CCCCC2)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 3/20 0.45
TSHR P16473 2/20 0.44
CCNT1 O60563 2/20 0.43
CCNA2 P20248 2/20 0.43
CDK2 P24941 2/20 0.43
CDK9 P50750 2/20 0.43
MAPK8 P45983 1/20 0.43
CDC7 O00311 1/20 0.43
DYRK1A Q13627 2/20 0.42
ALDH1A1 P00352 3/20 0.41
MAPK1 P28482 1/20 0.41
MEN1 O00255 2/20 0.41
HTT P42858 2/20 0.41
KMT2A Q03164 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
RECQL P46063 1/20 0.40
ATM Q13315 1/20 0.40
ADRB1 P08588 1/20 0.39
CHRNA7 P36544 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL421266 0.98 ACHE (0.46) ACHETSHRCCNT1CCNA2CDK2
SCHEMBL28058217 0.94 DYRK1A (0.43) ACHETSHRCCNT1CCNA2CDK2
SCHEMBL568877 0.81 PIK3CA (0.54) ACHETSHRCCNT1CCNA2CDK2
SCHEMBL573580 0.81 ADRB1 (0.59) ACHEALDH1A1ADRB1SMN1; SMN2USP2
SCHEMBL30635502 0.78 GBA1 (0.55) ACHECCNT1CCNA2CDK2CDK9
SCHEMBL27941842 0.78 GBA1 (0.55) ACHECCNT1CCNA2CDK2CDK9
SCHEMBL28059059 0.78 MAPK8 (0.47) ACHETSHRCCNT1CCNA2CDK2
SCHEMBL2088418 0.77 ALDH1A1 (0.46) ACHETSHRCCNT1CCNA2CDK2
SCHEMBL9900073 0.77 KDM1A (0.47) ACHECCNT1CCNA2CDK2CDK9
SCHEMBL12597157 0.77 KDM4E (0.55) ACHETSHRALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1206265-B1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2003-11-12 EP disclosed
US-6498165-B1 PYRIMIDINE COMPOUNDS; PROPHYLAXIS AND TREATMENT OF SUCH AS IMMUNE DISEASES, HYPERPROLIFERATIVE DISORDERS, CANCER, ANGIOGENSIS, ATHEROSCELEROSIS, GRAFT REJECTION, RHEUMATOID ARTHRITIS, PSORIASIS MERCK & CO., INC. 2002-12-24 US disclosed
EP-1206265-A4 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO INC (US) 2002-08-07 EP disclosed
EP-1206265-A1 SRC KINASE INHIBITOR COMPOUNDS Merck & Co., Inc. (US) 2002-05-22 EP disclosed
WO-2001000213-A1 SRC KINASE INHIBITOR COMPOUNDS MERCK & CO., INC. (US) 2001-01-04 WO disclosed